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Summary
Objective: The purpose of this study was to develop a new technique of gene transfer utilizing radial shock waves. The effects of radial shock
waves on gene transfer in rabbit chondrocytes were examined by varying the parameters of exposure conditions in vitro.
Methods: Chondrocytes were obtained from New Zealand white rabbits and cultured in a monolayer. A luciferase-encoding gene expression
vector, or vector alone, was added to chondrocyte cell suspensions, and the cells were then exposed to radial shock waves. Parameters such
as pressure amplitude, number of pulses, frequency, and DNA concentration were varied, and luciferase activity was measured 48 h after
transfection. Transfection efﬁciency of radial shock waves was compared with the FuGENE6 transfection method using a green ﬂuorescence
protein (GFP)-encoding gene vector by ﬂuorescent-activated cell sorter (FACS) analysis.
Results: Radial shock wave exposure signiﬁcantly increased luciferase activity over 140-fold as compared to the control under the optimal
exposure conditions. Both pressure amplitude and number of pulses were relevant to transfection efﬁciency and cell viability, but frequency
was not. Transfection efﬁciency increased in a dose-dependent manner with DNA concentration. FACS analysis showed 4.74% of GFP-
encoding gene using radial shock waves. FuGENE6 transfection was almost similar in transfection efﬁciency to radial shock wave.
Conclusion: In spite of certain degree of cell disruption, radial shock waves signiﬁcantly augmented reporter gene transfection in rabbit chon-
drocytes in vitro. Radial shock waves may potentially contribute to the treatment of the cartilage morbidities by enhancing the potency of tissue
healing and gene transfection of growth factors.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage morbidities such as osteoarthritis and traumatic
cartilage defect do not always respond to conventional con-
servative treatment. Surgical procedures such as mosaic
plasty or microfracture have shown stable clinical results
in many cases. Additionally, autologous chondrocyte trans-
plantation has been developed as a novel, improved treat-
ment of cartilage defect1 and gradually has become
popular. However, some drawbacks of these modalities in-
cluding, unsatisfactory results for larger defects, or elderly
cases of surgical procedures, high cost and adverse events
of autologous chondrocyte transplantation2, still remain un-
solved. Gene therapy can be considered a new treatment
candidate for cartilage lesions because it enables patients
to synthesize the medicative gene products endogenously,
and potentially in a prolonged and regulated manner.
Although clinical trials of gene therapy have been at-
tempted for cartilage morbidities, none of them have pro-
duced satisfactory results. The main reason for the delay
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Received 31 July 2006; revision accepted 3 April 2007.12in development of gene therapy in this ﬁeld seems to be
the lack of appropriate gene delivery systems for clinical
use. Successful gene therapy requires delivery systems
that are safe, easy to apply and that allow for efﬁcient trans-
gene expression. Viral methods have been shown to
deliver efﬁcient, uniform and continuous gene transfection
in vitro and in vivo3e5. Additionally, gene transfer of growth
factors using lentiviral or adeno-associated viral vectors
has been reported to improve the repair of articular carti-
lage defects in vivo6e9. However, the viral recombinant vec-
tors still have some disadvantages, including the need for
speciﬁc cell culture conditions10 and immune or inﬂa-
mmatory responses that adversely affect the cellular
phenotype11e13.
Meanwhile, non-viral plasmid DNA transfer has certain
advantages over viral methods. The mass-production and
quality control of non-viral vectors are substantially easier
than those of viral vectors. In addition, they can be trans-
ferred into quiescent cells without producing proteins that
raise immunogenic responses, while also being capable
of carrying a large molecule including plasmid DNA14e16.
Among many non-viral methods of transfection, ultra-
sound17e19 and focused extracorporeal shock waves20e23
have been investigated as physical means of improving
gene delivery. Since these new techniques suffer from
lower transfection efﬁciencies compared to viral methods,75
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full potential and overcome the adverse effects of conven-
tional viral techniques.
Ultrasound-mediated gene transfer is basically a safe,
easy and low-cost method. Addition of microbubble agents
has been reported to distinctly increase the efﬁciency of
gene transfer by ultrasound18,24,25. Although the elevation
of temperature in the target tissue is considered to be a possi-
ble adverse side effect of thismethod26, the clinical relevance
is controversial despite these studies27,28. Meanwhile, fo-
cused extracorporeal shock waves have shown relatively
high cytotoxicity and tissue damage22,23 aswell as a lower ef-
ﬁciency of gene transfer as compared to ultrasound29. The
bulk and expense of the device used to generate focused ex-
tracorporeal shock waves are suggested to be considerable
disadvantages in research and clinical applications.
Recently, radial shock wave was developed as a new type
of extracorporeal shock wave. Radial shock waves were uti-
lized in the veterinary ﬁeld ﬁrst, especially for equine muscu-
loskeletal disorders30. It has been shown that radial shock
waves have therapeutic effects when applied to the lateral
humeral epicondylitis, or so called ‘‘tennis elbow’’31. The
conventional devices for focused extracorporeal shock
waves have an exposure ﬁeld which is rotationally symmetric
around the axis, perpendicular to the surface of the genera-
tor, and the maximum energy is generated in the center of
the exposure area. On the other hand, the exposure area
of the radial shock waves radiates from the surface of the ap-
plicator and the energy gradually decreases depending on
the distance from the applicator. For the use of gene transfer,
the wide exposure area could be an advantage in covering
a larger area of target cells or tissues. The differences in
the size of the exposure ﬁeld and the property of energy
transmission between focused extracorporeal shock waves
and radial shock waves may have some impacts on cytotox-
icity and tissue damage as well as transfection efﬁciency.
The purpose of this study was to develop a new tech-
nique of gene transfer in chondrocytes utilizing radial shock
waves. We examined, for the ﬁrst time, the effects of radial
shock waves on transfection efﬁciency and cell viability by
varying the parameters of exposure conditions.
Materials and methods
PREPARATION OF PLASMID DNA
To test the efﬁciency of gene transfer, an expression vector
with a Cytomegarovirus (CMV) promoter encoding the lucif-
erase gene (pGV-C2, Toyo Ink Mfg. Co., Ltd., Tokyo, Japan)
and encoding green ﬂuorescence protein (GFP; pAcGFP1-
N1, BD Biosciences, Mountain View, CA, USA) were used.
The DNA plasmids were propagated in Escherichia coli
(HB101, Wako Pure Chemical Industries, Ltd., Osaka,
Japan). From the bacterial culture media, large quantities of
plasmid DNA amenable for transfections were prepared
using a chromatographic column from an EndoFree Plas-
mid Kit (Qiagen Inc., Chatsworth, CA, USA) as recommen-
ded by the manufacturer. Both expression vectors were
prepared at 1 mg/ml in the buffer solution (Transfection efﬁ-
ciency (TE) buffer pH8.0; 10mMTriseHCl, 1 mMEDTA:Eth-
ylenediaminetetraacetic acid) and stored at20C until use.
CELL PREPARATION
The experimental protocol was conducted in accordance
with the guidelines for animal experimentation of the EthicsReview Committee of Chiba University. Chondrocytes were
obtained by enzymatic digestion of the sliced cartilage from
the knee joints of New Zealand white rabbits at 4 weeks of
age. The chondrocytes were cultured in Dulbecco’s modi-
ﬁed eagle medium/Ham’s nutrient mixture F12 (DMEM/
F12), containing 10% fetal bovine serum, 50 mg/ml gentami-
cin, 360 mg/ml L-glutamine and 25 mg/ml ascorbic acid on
six-well plates until the cells reached conﬂuency. Cells
were trypsinized into 5 ml of medium with a trypsin-EDTA
solution (SigmaeAldrich, St. Louis, MO, USA) containing
5 mg/ml porcine trypsin and 2 mg/ml EDTA. Ten micrograms
of plasmid DNA encoding luciferase was added to each
well, 5 min before exposure to the radial shock waves.
The cell number of the cell suspension was maintained at
a constant 5.0 million per well in 5 ml of medium for all
experiments.
RADIAL SHOCK WAVE EXPOSURE
Radial shock waves were generated with a newly devel-
oped device, Swiss Dolorclast (Electro Medical Systems
SA, Switzerland). The applicator was placed in direct con-
tact with the prepared cell suspension from the upper side
of each well during the exposure period. Three parameters
were examined; exposure amplitude, number of pulses, and
frequency, to determine the optimal conditions of gene
transfer. The values of exposure amplitude used in this
study were 0.1, 0.2, 0.3 and 0.4 MPa. The number of pulses
was varied at 200, 500, 1000, 2000 and 5000. The effect of
frequency was tested at 5, 10 and 15 Hz. For each experi-
ment, the cell suspensions were kept at room temperature
(23e25C) during the shock wave exposure period. For
the control groups, the plasmid DNA encoding luciferase
was added to the cell suspension without the following ex-
posure to shock waves (RSW() group). Additionally, vec-
tor alone was added to the cell suspensions without shock
wave exposure (pLuc() group). Aliquots of the cells were
stained with 0.4% trypan blue to assess their viability imme-
diately after the exposure to shock waves at each condition.
The other cells were allowed to recover for 48 h after the ex-
posure in a 37C humidiﬁed incubator (5% CO2, 95% air).
EXAMINATION OF DNA CONCENTRATION
The effect of DNA concentration for the transfection efﬁ-
ciency had been also examined. The amount of DNA plas-
mid was varied at 5, 10, 20, 50 and 100 mg per sample. The
experiment was conducted under identical conditions to the
former investigation as to the parameters of exposure.
LUCIFERASE ASSAY
Luciferase gene expression was assessed by a standard
luciferase assay procedure as follows: after the removal of
culture media, cells were rinsed twice with phosphate-
buffered saline, followed by treatment with cell lysis buffer
(Toyo Ink Mfg. Co., Ltd., Tokyo, Japan). The samples
were stored at 80C until evaluation. After brief centrifuga-
tion (12,000g for 5 s), 20 ml of the supernatant (cell extract)
was mixed with 100 ml of luciferase assay reagent (Toyo Ink
Mfg. Co., Ltd., Tokyo, Japan) at room temperature. Lucifer-
ase activity was measured with a luminometer (ADVAN-
TEC, Tokyo, Japan) and expressed as relative light units
(RLU). The obtained data were normalized by total protein
content of each sample and used as the measure of trans-
fection efﬁciency (relative luciferase activity: RLU/mg).
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TRANSFECTION
For a direct comparison between the effects of radial
shock waves and another non-viral method of gene trans-
fer, we used the FuGENE6 Transfection Reagent (Roche,
Indianapolis, IN, USA). In the radial shock wave group
(RSW group), the cells were transfected with DNA encoding
GFP at the determined optimum condition of exposure and
DNA concentration. FuGENE6 transfection of DNA encod-
ing GFP for the chondrocytes was performed according to
the manufacturer’s instruction (FuGENE6 group). Cell
counts were conducted on the live cells by ﬂuorescent-
activated cell sorter (FACS) analysis. The GFP used in
this experiment has a maximum excitation of 490 nm and
emits light in the 520-mm range (according to the manufac-
turer). In the FACS, the cells were exposed to a 488-nm
light source and were detected at 530 15 nm. The back-
ground level of ﬂuorescence was determined by assaying
cells that had not been experimentally manipulated and set-
ting a threshold of ﬂuorescence above which cells were
deﬁned to be transfected (<0.5% of control cells). This
threshold was used to determine the transfection rate of
living cells. In all cases, 10,000 cells were counted.
STATISTICAL ANALYSIS
All numerical data, with the exception of the FACS data,
were represented by mean standard error. The statistical
signiﬁcance of the data was determined with Tukey’s test of




The effect of the radial shock wave exposure amplitude
on transfection efﬁciency and cell viability was examined
at a constant frequency of 10 Hz and 500 pulses (Fig. 1).
Relative luciferase activity showed a tendency to increase
with pressure amplitude (0.1 MPa: 3.42 0.06 RLU/mg;
0.2 MPa: 7.72 1.56 RLU/mg; 0.3 MPa: 16.41 2.16
RLU/mg; 0.4 MPa: 16.58 1.68 RLU/mg) [Fig. 1(A)]. The
relative luciferase activities at the conditions of 0.3 and
0.4 MPa were signiﬁcantly higher than those of the control
groups (RSW() group: 3.47 0.21 RLU/mg; pLuc()
group: 3.66 0.15 RLU/mg). Cell viability slightly de-
creased by the addition of plasmids (RSW() group:
89.4 0.6%; pLuc() group: 90.4 0.8%), and signiﬁcantly
decreased with increasing exposure amplitude up to
0.3 MPa (0.1 MPa: 65.6 0.6%; 0.2 MPa: 57.4 0.1%;
0.3 MPa: 43.0 0.7%; 0.4 MPa: 38.6 0.3%) [Fig. 1(B)].
Amplitude of 0.3 MPa was used for subsequent experi-
ments with variation of number of pulses and frequency,
since relative luciferase activity was considered to be satu-
rated at this condition.
NUMBER OF PULSES
Relative luciferase activity showed a tendency to increase
with increasing number of pulses and decreased at the con-
dition of 5000 pulses (200 pulses: 6.37 0.32 RLU/mg; 500
pulses: 16.41 2.16 RLU/mg; 1000 pulses: 23.89
3.53 RLU/mg; 2000 pulses: 78.39 4.73 RLU/mg; 5000
pulses: 16.21 0.74 RLU/mg) [Fig. 2(A)]. Cell viability
sharply decreased to 47.0 0.8% at 200 pulses, andremained steady with increasing number of pulses through
2000 (500 pulses: 43.0 0.7%; 1000 pulses: 45.0 1.4%;
2000 pulses: 39.4 0.3%). At 5000 pulses, cell viability de-
creased dramatically to 6.2 1.5% [Fig. 2(B)].
FREQUENCY
Relative luciferase activities of the shock wave-treated
groups were signiﬁcantly higher than those of the control
groups (RSW() group: 3.47 0.21 RLU/mg; pLuc()
group: 3.66 0.15 RLU/mg), which increased with increas-
ing frequency up to 10 Hz and slightly decreased at 15 Hz
(5 Hz: 136.9 17.8 RLU/mg; 10 Hz: 164.1 21.6 RLU/mg;
15 Hz: 105.3 7.9 RLU/mg), although the differences
among these groups were not statistically signiﬁcant
[Fig. 3(A)]. Cell viability slightly increased with frequency
(5 Hz: 41.0 0.4%; 10 Hz: 43.0 0.7%; 15 Hz: 46.0
0.8%) [Fig. 3(B)].
DNA CONCENTRATION
The optimal exposure condition of this experimental sys-
tem was determined from the former results; pressure ampli-
tude of 0.3 MPa, 2000 pulses, and a frequency of 10 Hz. This
set of conditions was employed during the examination of
DNAconcentration. Relative luciferase activity showeda ten-
dency to increase with increasing DNA concentration within
the limit of our experiment (5 mg: 4.66 2.79 RLU/mg;
Fig. 1. The relationship of pressure amplitude and relative lucifer-
ase activity (A) and cell viability (B). The cells were exposed
to radial shock waves at 500 pulses and a frequency of 10 Hz.
MeanþSE (n¼ 6), *P< 0.05.
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mg; 50 mg: 88.39 24.18 RLU/mg; 100 mg: 525.85
76.79 RLU/mg) [Fig. 4(A)]. At the concentration of 100 mg,
the transfection efﬁciency was more than 140-fold as
compared to the control groups (the RSW() group:
3.47 0.21 RLU/mg; the pLuc() group: 3.66 0.15 RLU/
mg), and it was signiﬁcantly higher than that in any other con-
dition that was tested in the current study. Cell viability
showed a tendency to decrease with DNA concentration
over the concentration of 10 mg, but it was not statistically sig-
niﬁcant [Fig. 4(B)].
FLOW CYTOMETRY
For the RSW group, the conditions of optimal exposure
and DNA concentration determined by former experiments
were used as reference; a pressure amplitude of 0.3 MPa,
2000 pulses, a frequency of 10 Hz, and DNA concentration
of 100 mg per sample. The RSW group showed a consider-
able uniform transfection pattern and a transfection efﬁ-
ciency of 4.74% [Fig. 5(A)]. Meanwhile, the FuGENE6
group also showed uniform transfection and a transfection
efﬁciency of 3.87% [Fig. 5(B)].
Discussion
This study demonstrated that radial shock waves induced
uniform gene transfer of a reporter gene to rabbit articular
chondrocytes. Transfection efﬁciency was augmented by
about 140-fold compared to the non-exposed control in
Fig. 2. The relationship of number of pulses and relative luciferase
activity (A) and cell viability (B). The cells were exposed to radial
shock waves at an amplitude of 0.3 MPa and a frequency of
10 Hz. MeanþSE (n¼ 6), *P< 0.05.particular condition with a certain degree of cell disruption
[Fig. 4(A)]. The optimal numerical value of transfection efﬁ-
ciency, which was determined by ﬂow cytometric analysis
showed 4.74% [Fig. 5(A)]. Recent studies utilizing focused
extracorporeal shock waves, and ultrasound, reported
transfection rates of up to 0.5e15%18,21,25,32 using naked
DNA, and 3- to 70-fold enhancements in reporter gene ex-
pression24,26,33. Despite the difference of the reporter gene
and the method of evaluation, the effect of radial shock
waves on gene transfer seems to be comparable to that
of focused extracorporeal shock waves, as well as ultra-
sound. On the other hand, FuGENE6 transfection resulted
in a transfection efﬁciency of 3.87%. This value is lower
than that has been expected since several methods of
non-viral gene transfer including lipofection and electro-
poration have been reported to show higher transfection
efﬁciency than our results34,35. We should be cautious to
discuss the merits of these methods of gene transfer con-
sidering many factors, i.e., transfection efﬁciency, costs,
safety. In spite of cell disruption and relatively low
efﬁciency, radial shock wave may have the advantage of
feasibility over other methods since it has been applied to
clinical subjects.
Extracorporeal shock waves, and ultrasound, induce the
physical phenomenon of cavitation, which is deﬁned as
the movement of newly formed and pre-existing gas bub-
bles containing gas or vapor in a ﬂuid36,37. A shear force
generated by cavitation leads to a transient permeabiliza-
tion of the cell membrane and enables uptake of exogenous
molecules, including plasmid DNA, into the target cells or
Fig. 3. The relationship of frequency and relative luciferase activity
(A) and cell viability (B). The cells were exposed to radial shock
waves at an amplitude of 0.3 MPa and 500 pulses. MeanþSE
(n¼ 6), *P< 0.05.
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able cytotoxicity and tissue damage. The main mechanism
of gene transfer by radial shock waves might be cavitation,
similar to other physical methods. Decreased cell viability
indicates that a certain level of cells was damaged by the
exposure to radial shock waves. Conversely, a sublethal
dose of cavitation may be responsible for permeabilization
of the cell membrane and successful gene transfer. For
the expression of a reporter gene, exposed cells have to
take up plasmid DNA and possess the capacity to actually
express the reporter gene25. These results might suggest
that the cell-speciﬁc property of the shearing force might
play an important role in gene transfer as a physical method
induced by the radial shock waves. Cell-speciﬁc optimiza-
tion which produces high transfection efﬁciency and simul-
taneously spares cell viability may be determined for each
cell line, or for each employed device generating various
types of ultrasound and shock waves.
The biological effect of cavitation exhibits a strong depen-
dence on both pressure amplitude and exposure time,
which is equivalent to the number of pulses28,29. We found
that transfection efﬁciency and cell viability depended on
pressure amplitude and number of pulses, which is consis-
tent with previous ﬁndings. However, the change in trans-
fection efﬁciency and cell viability did not demonstrate
a simply proportional pattern with pressure amplitude and
number of pulses. In the current study, there seemed to
be thresholds around the conditions of 0.3 MPa and 2000
pulses in which a prominent change of relative luciferase
activity and cell viability was observed (Figs. 1 and 2).
The cavitation threshold for transfection efﬁciency has
been shown in previous studies21,22,29. Furthermore, the
Fig. 4. The relationship of DNA concentration and relative luciferase
activity (A) and cell viability (B). The cells were exposed to radial
shock waves at an amplitude of 0.3 MPa, 2000 pulses, and a fre-
quency of 10 Hz. MeanþSE (n¼ 6), *P< 0.05.number of pulses is considered to be more relevant than
pressure amplitude in transfection efﬁciency, because the
relative luciferase activity at 2000 pulses showed the sharp-
est increase compared to any other level of pressure ampli-
tude (Figs. 1 and 2). Considering the uniform pattern of
transfection shown by FACS analysis, the decrease of
transfection efﬁciency at 5000 pulses was most likely
caused by severe cell disruption. The sharp decrease in
cell viability observed between 2000 and 5000 pulses is
difﬁcult to interpret. Several papers examining physical
methods of gene transfer have observed decreases in cell
viability proportional to increases in the number of
pulses25,27,28. With respect to the optimal number of pulses,
transfection efﬁciency would not likely continue to signiﬁ-
cantly increase once the number of pulses starts to exceed
2000 because of resultant decreases in cell viability. Thus,
pulse numbers exceeding 2000 shots should be avoided
because of the likelihood of resultant severe cell disruption
and consequent low transfection efﬁciency.
We could not ﬁnd apparent involvement of frequency in
transfection efﬁciency and cell viability (Fig. 3). Pressure
frequency has been reported to increase the number of cav-
itation events but has no inﬂuence on the cavitation bubble
lifespan and size39. Clinical tissue damage in lithotripsy de-
creases with frequency40. On the other hand, some previ-
ous studies have demonstrated that the biological effect
did not depend on frequency28,41. These conﬂicting ﬁndings
might be due to the difference of methodology, including tar-
get cell or tissue, or the employed device. Our experimental
protocol could not prove any contribution of frequency on
gene transfer.
Our results suggested that transfection efﬁciency was in-
creased with the concentration of DNA. However, transfec-
tion efﬁciency has been reported to be limited by more than
DNA concentration18,25,42. The decrease in the cell mem-
brane permeability would be determined by the exposure
conditions of the radial shock waves (i.e., the amount of
cavitation). Since passive induction of exogenous mole-
cules into the cell is caused by the decrease of permeabil-
ity, the allowable value of the transferred exogenous
molecules may be limited regardless of the concentration
of the exogenous molecules. Although the inﬂammatory
effect of DNA on the applied cell or tissue has been
reported19,43, our results did not show such an effect, as
in a decrease of cell viability with DNA concentration. The
cell disruption or inﬂammatory effect of DNA itself can be
negated, although a small number of cell disruptions (cell
viability of the RSW() group: 89.4 0.6%) was observed
by the addition of DNA.
The effect of extracorporeal shock waves on chondro-
cytes or cartilage tissue has not been sufﬁciently elucidated.
The potency of extracorporeal shock wave treatment has
been partly demonstrated in several ﬁndings, including the
expression of genes for osteogenesis44, the differentiation
of bone-marrow stromal cells45 and the signiﬁcant healing
of the tendonebone interface in animal studies46,47. Gene
transfer using radial shock waves can provide an opportu-
nity for enhancing these mechanisms when we supply the
gene coding for appropriate growth factors or medicative
proteins. On the other hand, macroscopic, radiological and
histological analyses after exposure of focused extracorpo-
real shockwave have shown no pathological changes in
the joint cartilage of growing rabbits48. This study suggested
that effective exposure of extracorporeal shockwave to
articular cartilage was prevented by some unknown me-
chanisms. The difference of acoustic impedance between
soft tissue and cartilage tissue and the heterogeneous
1280 R. Murata et al.: The effects of radial shock waves on gene transferFig. 5. Flow cytometric analysis of GFP expression in transfected cells by radial shock waves or FuGENE6 methods. The cells treated by
radial shock waves (RSW group: A) and FuGENE6 (FuGENE6 group: B) are shown. The dot plot of each group is shown as ﬂuorescence
of GFP (horizontal axis) and forward scatter (vertical axis). The cells within the sphere enclosed with a kinked line were analyzed and dis-
played in the histograms, respectively. In each histogram, the horizontal axis shows relative ﬂuorescent intensity and the vertical axis shows
cell numbers.distribution of joint ﬂuid, which is essential for the presence
of cavitation, may account for this phenomenon.
An ultrasound contrast agent consisting of microbubbles
was reported to dramatically enhance transfection efﬁciency
combined with ultrasound24,43. We did not include this factor
in this study since we intended to clarify the effect of radial
shock waves alone. The optimization of these factors, which
may be the subject of future investigation, is required to de-
velop a gene transfer method using radial shock waves.
The optimal conditions of this study may not be directly
applied to in vivo or clinical subjects. However, a compari-
son has demonstrated that in vivo pressure amplitude is
only 15e25% lower than the one measured in vitro49. The
attenuation of radial shock waves in vivo may be compen-
sated by increasing the output level of the device. Further-
more, the extent of tissue damage occurring in vivo, or in
clinical subjects is expected to be much less than that ob-
served in vitro50e53. Of further interest would be in vivo
studies involving use of animal models and transfection of
medicative genes, which may elucidate the prospects of
gene transfer using radial shock waves. However, the clin-
ical relevance of gene transfer by radial shock wave cannot
be determined at that time. The current study indicates that
low transfection efﬁciency and the potential for cell or tissue
damage are problems which remain as equally challengingfor radial shock wave therapy as for other non-viral
methods. At the same time, the study ﬁndings provide
encouragement that in the future, application of radial shock
wave-mediated gene therapy may help mitigate cartilage
morbidities.
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